FinanceCity
DiversifiedNSE · BSE

Indoco Remedies Ltd.

INDOCO · ISIN INE873D01024

Share price

₹236 -1.67%

Market capitalisation

₹2171 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹2171 Cr

Current price

₹236

-1.67% today

52W high

₹350

52W low

₹162

Stock P/E

P/B ratio

2.11

02 · Per share & returns

EPS (TTM)

-₹10.71

Book value

₹112

ROE

-10.12%

ROA

0.38%

Dividend yield

0.08%

Beta

0.57

03 · Financials (TTM)

By the numbers

Revenue

₹1845 Cr

+21.90% YoY

EBITDA

₹142 Cr

Net profit

₹-95.14 Cr

Profit margin

-5.16%

Operating margin

3.62%

Total debt

₹1090 Cr

Total cash

₹32.99 Cr

Debt / equity

1.17x

Current ratio

1.13x

Payout ratio

45.39%

04 · Analyst view

Target price

₹276

Upside

+17.27%

Consensus

NONE

Analysts

4

05 · Shareholding pattern

Who owns INDOCO?

Shareholding pattern not yet captured for this company. Pulled from NSE corporate filings on the next ownership refresh.

06 · Registration & listing

On the record

Symbol
INDOCO
Exchange
NSE · BSE
CIN
ISIN
INE873D01024
BSE code
532612
Sector
Diversified
Industry
Face value
₹2
Listing date
13 Jan 2005
Employees
6,000
Headquarters
Mumbai, India

07 · About

What is Indoco Remedies Ltd.?

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

08 · Common questions

Frequently asked

What is the CIN of Indoco Remedies Ltd.?+

The Corporate Identity Number for Indoco Remedies Ltd. is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Indoco Remedies Ltd.?+

Promoter and group-holding details for Indoco Remedies Ltd. are disclosed quarterly via stock-exchange filings. Detailed pattern is refreshed weekly here from BSE and NSE corporate filings.

What is the market capitalisation of Indoco Remedies Ltd.?+

Indoco Remedies Ltd. (INDOCO) has a market capitalisation of approximately ₹2171 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other diversified listings

Full sector →